# Labeling Requirements for Systemic Antibacterial Drug Products Intended for Human Use; Correction
> **Food and Drug Administration** · Final rule; correction. · Published 2003-03-17 · 68 FR 12584
## Document
- **Document number:** 03-6232
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 68 FR 12584
- **CFR reference:** 21 CFR 201
- **Publication date:** 2003-03-17
- **HHS docket:** Docket No. 00N-1463
## Abstract

The Food and Drug Administration (FDA) is correcting a final rule that appeared in the Federal Register of February 6, 2003 (68 FR 6062). The document amended FDA's regulations to require that the labeling for all systemic antibacterial drug products intended for human use include certain statements about using antibiotics in a way that will reduce the development of drug-resistant bacterial strains. The document was published with an inadvertent error. This document corrects that error.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2003/03/17/03-6232/labeling-requirements-for-systemic-antibacterial-drug-products-intended-for-human-use-correction)
---
*AI Analytics · CC0 1.0*